Your browser doesn't support javascript.
loading
The kinetics and durability of antibody and T-cell responses to SARS-CoV-2 in children.
Files, Megan A; Gentles, Lauren; Kehoe, Leanne; Adler, Amanda; Lacombe, Kirsten; Dickerson, Jane A; Greninger, Alexander; Waghmare, Alpana; Fairlie, Tarayn; Pringle, Kimberly; Midgley, Claire M; Hagen, Melissa Briggs; Englund, Janet A; Seshadri, Chetan.
  • Files MA; Department of Medicine, University of Washington School of Medicine, Seattle, WA  USA.
  • Gentles L; Fred Hutchinson Cancer Center, Seattle, WA  USA.
  • Kehoe L; Seattle Children's Research Institute, Seattle, WA  USA.
  • Adler A; Seattle Children's Research Institute, Seattle, WA  USA.
  • Lacombe K; Seattle Children's Research Institute, Seattle, WA  USA.
  • Dickerson JA; Seattle Children's Research Institute, Seattle, WA  USA.
  • Greninger A; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA  USA.
  • Waghmare A; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, WA  USA.
  • Fairlie T; Fred Hutchinson Cancer Center, Seattle, WA  USA.
  • Pringle K; Seattle Children's Research Institute, Seattle, WA  USA.
  • Midgley CM; Department of Pediatrics, University of Washington, Seattle, WA  USA.
  • Hagen MB; Coronavirus and Other Respiratory Viruses Division, National Center for immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA  USA.
  • Englund JA; Coronavirus and Other Respiratory Viruses Division, National Center for immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA  USA.
  • Seshadri C; Coronavirus and Other Respiratory Viruses Division, National Center for immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA  USA.
J Infect Dis ; 2024 Jun 05.
Article en En | MEDLINE | ID: mdl-38838218
ABSTRACT

BACKGROUND:

The kinetics and durability of T-cell responses to SARS-CoV-2 in children are not well-characterized. We studied a cohort of children aged 6 months to 20 years with COVID-19 in whom peripheral blood mononuclear cells (PBMC) and sera were archived at approximately 1, 6, and 12 months post-symptom onset.

METHODS:

We compared antibody (N = 85) and T-cell responses (N = 26) to nucleocapsid (N) and spike (S) glycoprotein over time across four age strata 6 months to 5 years, 5-9, 10-14, and 15-20 years.

RESULTS:

N-specific antibody responses declined over time, becoming undetectable in 26/32 (81%) children by approximately one year post-infection. Functional breadth of anti-N CD4+ T-cell responses also declined over time and were positively correlated with N-antibody responses (Pearson's r = 0.31, p = 0.008). CD4+ T-cell responses to S displayed greater functional breadth than N in unvaccinated children, and, along with neutralization titers, were stable over time and similar across age strata. Functional profiles of CD4+ T-cell responses against S were not significantly modulated by vaccination.

CONCLUSIONS:

Our data reveal durable, age-independent T-cell immunity to SARS-CoV-2 structural proteins in children over time following COVID-19 infection as well as S-Ab responses overall, in comparison to declining antibody responses to N.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article